Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017)

BACKGROUND: As daily oral pre-exposure prophylaxis (PrEP) becomes standard for HIV prevention, routine use of PrEP is likely to increase within clinical trials of novel preventive agents. We describe the prevalence and characteristics of participants reporting non-study oral PrEP use within Microbic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Acquir Immune Defic Syndr
Main Authors: Liu, Albert Y., Norwood, Aliza, Gundacker, Holly, Carballo-Diéguez, Alex, Johnson, Sherri, Patterson, Karen, Bekker, Linda-Gail, Chariyalertsak, Suwat, Chitwarakorn, Anupong, Gonzales, Pedro, Holtz, Timothy H., Mayer, Kenneth H., Zorrilla, Carmen, Buchbinder, Susan, Piper, Jeanna M., Lama, Javier R., Cranston, Ross D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6629432/
https://ncbi.nlm.nih.gov/pubmed/31299013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002066
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados